X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (7027) 7027
Book Review (1007) 1007
Publication (964) 964
Conference Proceeding (197) 197
Book Chapter (82) 82
Dissertation (41) 41
Book / eBook (28) 28
Newsletter (13) 13
Web Resource (3) 3
Microfilm (2) 2
Government Document (1) 1
Magazine Article (1) 1
Paper (1) 1
Video Recording (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (4701) 4701
kras (4450) 4450
humans (4185) 4185
oncology (3185) 3185
mutation (2750) 2750
female (2274) 2274
male (2044) 2044
cancer (1975) 1975
colorectal cancer (1789) 1789
middle aged (1751) 1751
aged (1626) 1626
adult (1263) 1263
ras proteins - genetics (1257) 1257
genetic aspects (1142) 1142
colorectal neoplasms - genetics (1122) 1122
chemotherapy (1099) 1099
proto-oncogene proteins - genetics (1097) 1097
proto-oncogene proteins p21 (1082) 1082
egfr (1049) 1049
cetuximab (1045) 1045
braf (1021) 1021
tumors (1019) 1019
prognosis (995) 995
animals (972) 972
kras mutations (939) 939
aged, 80 and over (908) 908
pathology (885) 885
colorectal neoplasms - pathology (879) 879
metastasis (870) 870
proto-oncogene proteins p21 - genetics (860) 860
adenocarcinoma (848) 848
lung neoplasms - genetics (800) 800
analysis (790) 790
research (757) 757
proto-oncogene proteins b-raf - genetics (738) 738
expression (720) 720
survival (702) 702
lung cancer (697) 697
cell biology (695) 695
gene mutations (679) 679
colorectal neoplasms - drug therapy (661) 661
mutations (659) 659
care and treatment (642) 642
kras mutation (625) 625
article (618) 618
mice (613) 613
growth-factor receptor (611) 611
cell line, tumor (610) 610
digestive system diseases (605) 605
neoplasms (594) 594
adenocarcinoma - genetics (586) 586
pancreatic cancer (572) 572
therapy (571) 571
biomarkers, tumor - genetics (552) 552
k-ras (550) 550
carcinoma (542) 542
dna mutational analysis (534) 534
lung neoplasms - pathology (527) 527
1st-line treatment (512) 512
microsatellite instability (505) 505
receptor, epidermal growth factor - genetics (476) 476
panitumumab (467) 467
carcinoma, non-small-cell lung - genetics (464) 464
health aspects (462) 462
antineoplastic agents - therapeutic use (449) 449
respiratory system (449) 449
colorectal-cancer (446) 446
neoplasm staging (441) 441
colon-cancer (439) 439
immunohistochemistry (435) 435
mutation - genetics (431) 431
biochemistry & molecular biology (430) 430
gefitinib (429) 429
genes (425) 425
signal transduction (422) 422
treatment outcome (411) 411
retrospective studies (399) 399
epidermal growth factor (394) 394
proteins (389) 389
adenocarcinoma - pathology (388) 388
cell lung-cancer (384) 384
gene (383) 383
development and progression (376) 376
antineoplastic combined chemotherapy protocols - therapeutic use (374) 374
kinases (374) 374
polymerase chain reaction (373) 373
gene expression (371) 371
patients (368) 368
deoxyribonucleic acid--dna (366) 366
ras (366) 366
disease-free survival (362) 362
surgery (362) 362
receptor, epidermal growth factor - antagonists & inhibitors (358) 358
biomarkers (353) 353
genes, ras (351) 351
activation (350) 350
medicine & public health (350) 350
metastatic colorectal-cancer (348) 348
neoplasm metastasis (347) 347
gastroenterology & hepatology (340) 340
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (8) 8
Online Resources - Online (5) 5
Gerstein Science - Stacks (4) 4
Earth Sciences (Noranda) - Stacks (3) 3
Royal Ontario Museum - Periodical Stacks (3) 3
Royal Ontario Museum - Stacks (3) 3
UTL at Downsview - May be requested (3) 3
UofT at Mississauga - Stacks (3) 3
Collection Dvlpm't (Acquisitions) - Vendor file (2) 2
Media Commons - Microtexts (2) 2
New College (Ivey) - Stacks (2) 2
Collection Dvlpm't (Acquisitions) - Cancelled Order (1) 1
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
OISE - Stacks (1) 1
UofT at Scarborough - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (7061) 7061
French (85) 85
German (38) 38
Spanish (29) 29
Chinese (28) 28
Lithuanian (18) 18
Russian (16) 16
Japanese (13) 13
Slovenian (13) 13
Korean (10) 10
Czech (9) 9
Hungarian (6) 6
Polish (6) 6
Italian (5) 5
Persian (3) 3
Swedish (3) 3
Croatian (2) 2
Dutch (1) 1
Greek (1) 1
Malay (1) 1
Portuguese (1) 1
Serbian (1) 1
Slovak (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2011, Cambridge studies in biological and evolutionary anthropology, ISBN 9780521764339, Volume 60, xvii, 360
"Long-tailed macaques (Macaca fascicularis) have a wide geographical distribution and extensively overlap with human societies across southeast Asia, regularly... 
Effect of human beings on | Ecology | Kra | Conservation
Book
11/2013
Colorectal cancer (CRC) is the third leading cause of death from cancer in North America. The KRAS gene is mutated in approximately 40-50% of all CRC, and this... 
0379 | c-MET | KRAS
Dissertation
CANCER RESEARCH, ISSN 0008-5472, 05/2019, Volume 79, Issue 10, pp. 2462 - 2465
Cancer is one of the leading causes of death worldwide. This life-threatening disease requires novel strategies for the early detection and therapy response... 
ONCOLOGY | CANCER | KRAS
Journal Article
Journal Article
JOURNAL OF MEDICINAL CHEMISTRY, ISSN 0022-2623, 04/2019, Volume 62, Issue 8, pp. 4131 - 4141
Sirtuin 2 (SIRT2) is a protein lysine deacylase that has been indicated as a therapeutic target for cancer. To further establish the role of SIRT2 in cancers,... 
KRAS MUTATIONS | SPECIFICITY | CHEMISTRY, MEDICINAL
Journal Article
International Journal of Pharmaceutics, ISSN 0378-5173, 04/2019, Volume 561, pp. 114 - 123
KRAS is a small GTPase that regulates cell proliferation and survival. In tumors, the KRAS gene is mutated, and leading to unregulated tumor growth. Despite... 
Hyaluronan | siRNA | KRAS | CD44 | Polymer therapeutics | EFFICACY | ONCOGENIC KRAS | DOXORUBICIN | CHITOSAN NANOPARTICLES | HYALURONIC-ACID | MUTANT KRAS | THERAPY | K-RAS | PHARMACOLOGY & PHARMACY | INHIBITORS | EXPRESSION
Journal Article
MOLECULAR CANCER THERAPEUTICS, ISSN 1535-7163, 03/2019, Volume 18, Issue 3, pp. 613 - 620
Pancreatic ductal adenocarcinoma (PDAC) remains remarkably lethal with a 5-year survival rate of 8%. This is mainly attributed to the late stage of... 
KRAS | ONCOLOGY | ADENOCARCINOMA | IMMUNE EVASION
Journal Article
FUTURE MEDICINAL CHEMISTRY, ISSN 1756-8919, 05/2019, Volume 11, Issue 9, pp. 923 - 925
Journal Article
Journal Article
Journal of Maps, ISSN 1744-5647, 11/2016, Volume 12, Issue sup1, pp. 352 - 362
The paper aims to present the geology of the western part of the Classical Karst (NW Dinarides), located at the border between Slovenia and Italy. The work is... 
Kras-Carso | Italy | Classical Karst | Slovenia | Geology | Dinarides | Kras–Carso | ISTRIA | CROATIA | GEOGRAPHY, PHYSICAL | EVOLUTION | PALEOGEOGRAPHY | CARBONATE PLATFORM | KOMEN | KRAS | GEOGRAPHY
Journal Article
Cell Reports, ISSN 2211-1247, 08/2019, Volume 28, Issue 6, pp. 1538 - 1550.e7
Ras GTPases are mutated at codons 12, 13, and 61, with different frequencies in KRas, HRas, and NRas and in a cancer-specific manner. The G13D mutant appears... 
Ras conformational states | colorectal cancer | Ras GTPases | activation cycle | KRas G13D mouse model | KRas G12D | KRas G13D structures | oncogene | nucleotide exchange mutant | Index Medicus
Journal Article
by Kubicka Prof, Stefan and Greil, R and André, T and Bennouna, J and Sastre, J and Van Cutsem, E and Von Moos, R and Österlund, P and Reyes-Rivera, I and Müller, T and Makrutzki, M and Arnold, D and Andel, J and Balcke, P and Benedicic, B and Eisterer, W and Fridrik, M and Jagdt, B and Keil, F and Kretschmer, A and Krippl, P and Oexle, H and Pecherstorfer, M and Samonigg, H and Schmid, M and Thaler, J and Tinchon, C and Weiss, H and Arts, J and De Man, M and Demolin, G and Janssens, J and Polus, M and Benczikova, B and Melichar, B and Prausova, J and Vitek, P and Andersen, F.Z and Jensen, B.B and Keldsen, N and Østerlind, K and Vistisen, K and Elme, A and Magi, A and Ojamaa, K and Ristamäki, R and Salminen, T and Ben Abdelghani, M and Bouche, O and Borg, C and Bouhier-Leporrier, K and Breysacher, G and Chone, L and Clavero Fabri, M.-C and Deplanque, G and Desseigne, F and Dourthe, L.-M and Ezenfis, J and Faroux, R and François, E and Garnier, C and Gaspard, M.-H and Hebbar, M and Illory, J.F and Kaminsky, M.-C and Lecomte, T and Legoux, J.-L and Levache, B and Lobry, C and Lotz, J.-P and Mabro, M and Manet-Lacombe, S and Manfredi, S and Matysiak Budnik, T and Miglianico, L and Mineur, L and Moullet, I and Naman, H and Nouyrigat, P and Oziel-Taieb, S and Perrier, H and Pezet, D and Philip, J and Pottier, V and Porneuf, M and Ramdani, M and Re, D and Rinaldi, Y and Spaeth, D and Taieb, J and Terrebonne, E and Texereau, P and Thirot Bidault, A and Tournigand, C and Tubiana-Mathieu, N and Vantelon, J.-M and Viret, F and Ychou, M and Bangerter, M and Bertram, M.E and ...
Annals of Oncology, ISSN 0923-7534, 09/2013, Volume 24, Issue 9, pp. 2342 - 2349
Journal Article
Acta Oto-Laryngologica, ISSN 0001-6489, 07/2019, Volume 139, Issue 7, pp. 647 - 651
Background: p16 INK4a (p16) expression in tongue cancer (TC) is reportedly not associated with human papilloma virus (HPV). Mutations of KRAS in cancer cells... 
tongue cancer | KRAS | p16 INK4a
Journal Article
Nature, ISSN 0028-0836, 06/2012, Volume 486, Issue 7404, pp. 532 - 536
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 5/2015, Volume 112, Issue 21, pp. 6625 - 6630
Journal Article
Cancer Research, ISSN 0008-5472, 2019, Volume 79, Issue 9, pp. 2352 - 2366
Combinatorial inhibition of MEK1/2 and CDK4/6 is currently undergoing clinical investigation in NRAS-mutant melanoma. To prospectively map the landscape of... 
DEPENDENCY | ONCOLOGY | SENSITIVITY | KRAS | SCALE | COMBINATION | CANCER
Journal Article
by Chen, H and Fan, K and Luo, GP and Fan, ZY and Yang, C and Huang, QY and Jin, KZ and Xu, J and Yu, XJ and Liu, C
CANCER LETTERS, ISSN 0304-3835, 2019, Volume 446, pp. 103 - 111
Genetic alterations have been attributed to the abnormal immune microenvironment in cancer. However, the relationship between the Kras(G12D) mutation and... 
Immunosuppressive | TGF-beta | PEPTIDES | ONCOLOGY | PROGNOSIS | SUBTYPES | Pancreatic cancer | ONCOGENIC KRAS | VACCINATION | Kras(G12D) mutation | IL-10
Journal Article
BRITISH JOURNAL OF CANCER, ISSN 0007-0920, 07/2019, Volume 121, Issue 3, pp. 197 - 198
Summary Despite its status as the most commonly mutated oncogene in cancer, Ras has long been considered ‘undruggable’. In 2019, we will see the first clinical... 
ONCOLOGY | CANCER | KRAS | Inhibitors | Index Medicus
Journal Article